Citigroup’s Sonoma Pharmaceuticals SNOA Stock Holding History
Bought
Maintained
Sold
Other funds holding SNOA
VCM
DS
MCWS
TRCT
VFT
Citigroup's SNOA Position: Q1 2026 in Review
Citigroup opened a new position in Sonoma Pharmaceuticals (SNOA) in Q1 2026: 1,425 shares worth $3.04K. The stake represents ﹤0.01% of the portfolio and ranks #5363 among its holdings. This is a return to the name: Citigroup previously reported a position in SNOA as recently as Q3 2025.
Citigroup first reported a position in SNOA in Q4 2014 and has held it in 7 quarters since. 17 funds tracked by Wall St. Rank hold SNOA as of Q1 2026.
- Citigroup held 1,425 shares of Sonoma Pharmaceuticals worth $3.04K as of Q1 2026.
- Sonoma Pharmaceuticals was a new Citigroup position in Q1 2026.
- Sonoma Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5363 holding.
- Citigroup first reported a position in Sonoma Pharmaceuticals in Q4 2014 and has held it in 7 quarters since.
- 17 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.